Literature DB >> 19576341

Trends in atrial fibrillation complicating acute myocardial infarction.

Jane S Saczynski1, David McManus, Zheng Zhou, Frederick Spencer, Jorge Yarzebski, Darleen Lessard, Joel M Gore, Robert J Goldberg.   

Abstract

Atrial fibrillation (AF) is a common complication of acute myocardial infarction (AMI) and this arrhythmia is associated with increased morbidity and mortality in patients with AMI. Limited information is available, however, about changing, and contemporary, trends in the incidence and death rates associated with AF complicating AMI. We examined the magnitude and impact of AF and the risk of stroke and hospital and long-term death rates in a population-based study of patients hospitalized with AMI. The study population consisted of 7,513 residents of the Worcester, Massachusetts, metropolitan area hospitalized with AMI at all greater Worcester medical centers during 9 biennial years from 1990 to 2005. Overall incidence of AF complicating AMI was 13.3% and rates of AF increased during the most recent years under study. Patients who developed AF were at greater risk for acute stroke (adjusted odds ratio 2.25, 95% confidence interval 1.36 to 3.71) and dying during hospitalization (adjusted odds ratio 1.79, 95% confidence interval 1.46 to 2.19) compared with patients who did not develop AF during hospitalization for AMI. Postdischarge survival was significantly poorer in patients who developed AF. Odds of dying after AF did not change appreciably over the years under study. In conclusion, results of this study in residents of a large New England metropolitan area suggest that AF remains a frequent complication of AMI and is associated with a poor prognosis. Increased surveillance and targeted therapeutic approaches appear warranted for these high-risk patients.

Entities:  

Mesh:

Year:  2009        PMID: 19576341      PMCID: PMC4565159          DOI: 10.1016/j.amjcard.2009.03.011

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  15 in total

1.  Twenty year trends (1975-1995) in the incidence, in-hospital and long-term death rates associated with heart failure complicating acute myocardial infarction: a community-wide perspective.

Authors:  F A Spencer; T E Meyer; R J Goldberg; J Yarzebski; M Hatton; D Lessard; J M Gore
Journal:  J Am Coll Cardiol       Date:  1999-11-01       Impact factor: 24.094

2.  New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experience.

Authors:  C K Wong; H D White; R G Wilcox; D A Criger; R M Califf; E J Topol; E M Ohman
Journal:  Am Heart J       Date:  2000-12       Impact factor: 4.749

3.  A two-decades (1975 to 1995) long experience in the incidence, in-hospital and long-term case-fatality rates of acute myocardial infarction: a community-wide perspective.

Authors:  R J Goldberg; J Yarzebski; D Lessard; J M Gore
Journal:  J Am Coll Cardiol       Date:  1999-05       Impact factor: 24.094

4.  Preventing stroke in patients with atrial fibrillation.

Authors:  M D Ezekowitz; J A Levine
Journal:  JAMA       Date:  1999-05-19       Impact factor: 56.272

5.  Recent trends in the incidence rates of and death rates from atrial fibrillation complicating initial acute myocardial infarction: a community-wide perspective.

Authors:  Robert J Goldberg; Jorge Yarzebski; Darleen Lessard; Jacqueline Wu; Joel M Gore
Journal:  Am Heart J       Date:  2002-03       Impact factor: 4.749

6.  Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.

Authors:  B S Crenshaw; S R Ward; C B Granger; A L Stebbins; E J Topol; R M Califf
Journal:  J Am Coll Cardiol       Date:  1997-08       Impact factor: 24.094

7.  Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation.

Authors:  R D Lopes; K S Pieper; J R Horton; S M Al-Khatib; L K Newby; R H Mehta; F Van de Werf; P W Armstrong; K W Mahaffey; R A Harrington; E M Ohman; H D White; L Wallentin; C B Granger
Journal:  Heart       Date:  2008-03-10       Impact factor: 5.994

Review 8.  Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications.

Authors:  Joern Schmitt; Gabor Duray; Bernard J Gersh; Stefan H Hohnloser
Journal:  Eur Heart J       Date:  2008-12-24       Impact factor: 29.983

9.  Recent changes in attack and survival rates of acute myocardial infarction (1975 through 1981). The Worcester Heart Attack Study.

Authors:  R J Goldberg; J M Gore; J S Alpert; J E Dalen
Journal:  JAMA       Date:  1986 May 23-30       Impact factor: 56.272

10.  Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation.

Authors:  Rajendra H Mehta; Omar H Dabbous; Christopher B Granger; Polina Kuznetsova; Eva M Kline-Rogers; Frederick A Anderson; Keith A A Fox; Joel M Gore; Robert J Goldberg; Kim A Eagle
Journal:  Am J Cardiol       Date:  2003-11-01       Impact factor: 2.778

View more
  43 in total

1.  Declining length of stay for patients hospitalized with AMI: impact on mortality and readmissions.

Authors:  Jane S Saczynski; Darleen Lessard; Frederick A Spencer; Jerry H Gurwitz; Joel M Gore; Jorge Yarzebski; Robert J Goldberg
Journal:  Am J Med       Date:  2010-11       Impact factor: 4.965

2.  Thirty-day Hospital Readmissions in Patients with Non-ST-segment Elevation Acute Myocardial Infarction.

Authors:  Mayra Tisminetzky; David D McManus; Nathaniel Erskine; Jane S Saczynski; Jorge Yarzebski; Edgard Granillo; Joel Gore; Robert J Goldberg
Journal:  Am J Med       Date:  2015-02-03       Impact factor: 4.965

3.  Anticoagulation strategies in patients with atrial fibrillation after PCI or with ACS : The end of triple therapy?

Authors:  N Fluschnik; P M Becher; R Schnabel; S Blankenberg; D Westermann
Journal:  Herz       Date:  2018-02       Impact factor: 1.443

4.  30-year trends in patient characteristics, treatment practices, and long-term outcomes of adults aged 35 to 54 years hospitalized with acute myocardial infarction.

Authors:  Mayra Tisminetzky; David D McManus; Joel M Gore; Jorge Yarzebski; Andrew Coles; Darleen Lessard; Robert J Goldberg
Journal:  Am J Cardiol       Date:  2014-01-14       Impact factor: 2.778

5.  Decade-long trends in the characteristics, management and hospital outcomes of diabetic patients with ST-segment elevation myocardial infarction.

Authors:  Mayra Tisminetzky; Samuel Joffe; David D McManus; Chad Darling; Joel M Gore; Jorge Yarzebski; Darleen Lessard; Robert J Goldberg
Journal:  Diab Vasc Dis Res       Date:  2014-03-11       Impact factor: 3.291

6.  Encouraging trends in acute myocardial infarction survival in the oldest old.

Authors:  Jennifer Tjia; Jeroan Allison; Jane S Saczynski; Mayra Tisminetzky; Jane L Givens; Kate Lapane; Darleen Lessard; Robert J Goldberg
Journal:  Am J Med       Date:  2013-07-05       Impact factor: 4.965

Review 7.  Mortality Risk Associated with AF in Myocardial Infarction Patients.

Authors:  Rajiv Sankaranarayanan
Journal:  J Atr Fibrillation       Date:  2012-10-06

Review 8.  The Relationship Between Atrial Fibrillation and Chronic Kidney Disease : Epidemiologic and Pathophysiologic Considerations for a Dual Epidemic.

Authors:  David D McManus; Jane S Saczynski; Jeanine A Ward; Khushleen Jaggi; Peter Bourrell; Chad Darling; Robert J Goldberg
Journal:  J Atr Fibrillation       Date:  2012-06-15

9.  Trends in atrial fibrillation in patients hospitalized with an acute coronary syndrome.

Authors:  David D McManus; Wei Huang; Kunal V Domakonda; Jeanine Ward; Jane S Saczysnki; Joel M Gore; Robert J Goldberg
Journal:  Am J Med       Date:  2012-11       Impact factor: 4.965

10.  Atrial fibrillation in myocardial infarction patients: Impact on health care utilization.

Authors:  Alanna M Chamberlain; Suzette J Bielinski; Susan A Weston; Winslow Klaskala; Roger M Mills; Bernard J Gersh; Alvaro Alonso; Véronique L Roger
Journal:  Am Heart J       Date:  2013-08-17       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.